Casey Lynch - 03 Jan 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role: Chief Executive Officer, Director
Signature: /s/ Caryn Gordon McDowell, as Attorney-in-Fact for Casey C. Lynch
Issuer symbol: QNCX
Transactions as of: 03 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2022, 16:26:18 UTC
Previous filing: 19 Nov 2021
Next filing: 31 May 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNCX	Stock Option (right to buy)	Award	$0	+440,000		$0.000000	440,000	03 Jan 2022	Common Stock	440,000	$13.39	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the date of grant, such that the total number of shares shall be fully vested on the four-year anniversary of the date of grant.